Impax Laboratories, Inc.
Volume 164 · 164 F.T.C. 1063
Cite this decision
Impax Laboratories, Inc., 164 F.T.C. 1063 (2017). Consumer Law Library, https://consumerlawlibrary.org/decisions/v164-0022
Report an error in this record (decision id v164-0022)
Cited by 0 later FTC decisions
Cites
Text (OCR of the scan at left; may contain errors)
IN THE MATTER OF IMPAX LABORATORIES, INC.
Docket No. 9373. Order, August 14, 2017 Order granting respondent’s motion seeking a revised deadline for its Opposition to Complaint Counsel’s Motion for Partial Summary Decision. ORDER GRANTING RESPONDENT’S MOTION FOR EXTENSION OF TIME On August 8, 2017, Respondent Impax Laboratories, Inc. (“Impax”) filed a Motion and Memorandum of Law in Support of Motion for Extension of Deadline for Opposing Complaint Counsel’s Motion for Partial Summary Decision. Impax seeks a revised deadline of August 31, 2017 for its Opposition to Complaint Counsel’s August 4, 2017 Motion for Partial Summary Decision.
Pursuant to Commission Rule 4.3(b), 16 C.F.R. § 4.3(b), the Commission has determined, for good cause shown, to grant the Motion. Accordingly, IT IS ORDERED that Respondent’s Motion is GRANTED. Respondent must file its response to Complaint Counsel’s Motion for Partial Summary Decision on or before August 31, 2017. By the Commission.
VOLUME 164 Interlocutory Orders, Etc.